EBLN3P and acute lymphoblastic leukemia: Our study is the first to demonstrate that lncRNA EBLN3P is dysregulated in T-ALL, and lncRNA EBLN3P knockdown may inhibit the malignant biological behaviors of T-ALL cells by preventing the sponging of miR-655-3p, providing a new potential therapeutic target for T-ALL.